- E-mailhugo.jorgensen@uib.no
- Visitor AddressHaukeland Universitetssykehus Laboratoriebygget, 7. etg. Heis øst5009 Bergen
- Postal AddressPostboks 78045020 Bergen
Academic article
- (2022). Akathisia and atypical antipsychotics. Relation to suicidality, agitation and depression in a clinical trial. Acta Neuropsychiatrica. 282-288.
- (2021). The Influence of Substance Use on Side Effects of Olanzapine, Quetiapine, Risperidone, and Ziprasidone in Psychosis. Substance Use & Misuse. 1880-1891.
- (2020). Different response patterns in hallucinations and delusions to antipsychotic treatment. Nordic Journal of Psychiatry. 497-504.
- (2019). The influence of substance use on the effectiveness of antipsychotic medication: a prospective, pragmatic study. Nordic Journal of Psychiatry. 281-287.
- (2019). Predictors of treatment satisfaction in antipsychotic-naive and previously medicated patients with acute-phase psychosis. Nordic Journal of Psychiatry. 349-356.
- (2018). Trajectories of depressive symptoms in the acute phase of psychosis: Implications for treatment. Journal of Psychiatric Research. 219-228.
- (2018). Associations between C-reactive protein levels and cognition during the first 6 months after acute psychosis. Acta Neuropsychiatrica. 1-10.
- (2016). The serum level of C-reactive protein (CRP) is associated with cognitive performance in acute phase psychosis. BMC Psychiatry.
- (2016). The course of neurocognitive changes in acute psychosis: Relation to symptomatic improvement. PLOS ONE. 13 pages.
- (2016). Patient satisfaction after acute admission for psychosis. Nordic Journal of Psychiatry. 321-328.
- (2016). Influence of different second generation antipsychotics on the QTC interval: A pragmatic study. World Journal of Psychiatry (WJP). 442-448.
- (2015). Suicidality in schizophrenia spectrum disorders: The relationship to hallucinations and persecutory delusions. European psychiatry. 830-836.
- (2015). Borderline personality disorder and posttraumatic stress disorder at psychiatric discharge predict general hospital admission for self-harm. Journal of Traumatic Stress. 556-562.
- (2015). Auditory verbal hallucinations reflect stable auditory attention deficits: A prospective study. Cognitive Neuropsychiatry. 81-94.
- (2014). Time to discontinuation of antipsychotic drugs in a schizophrenia cohort: influence of current treatment strategies. Therapeutic Advances in Psychopharmacology. 228-239.
- (2014). Self-harm induced somatic admission after discharge from psychiatric hospital - a prospective cohort study. European psychiatry. 246-252.
- (2014). Do auditory verbal hallucinations in the acute phase of psychosis reflect stable cognitive impairments seen also in a more stabilised clinical phase? Cognitive Neuropsychiatry. 81-94.
- (2014). Cognitive changes in patients with acute phase psychosis - Effects of illicit drug use. Psychiatry Research. 818-824.
- (2013). The influence of glutamatergic antagonism on motor variability, and comparison to findings in schizophrenia patients. Acta Neuropsychiatrica. 105-112.
- (2013). QTc prolongation in patients acutely admitted to hospital for psychosis and treated with second generation antipsychotics. Schizophrenia Research and Treatment.
- (2013). Prospective and concurrent correlates of emotion perception in psychotic disorders: A naturalistic, longitudinal study of neurocognition, affective blunting and avolition. Scandinavian Journal of Psychology. 261-266.
- (2013). Neurocognitive effectiveness of quetiapine, olanzapine, risperidone, and ziprasidone: A pragmatic, randomized trial. European psychiatry. 174-184.
- (2013). Hallucinations in acutely admitted patients with psychosis, and effectiveness of risperidone, olanzapine, quetiapine, and ziprasidone: a pragmatic, randomized study. BMC Psychiatry.
- (2012). Time-dependent effect analysis of antipsychotic treatment in a naturalistic cohort study of patients with schizophrenia. European psychiatry. 489-495.
- (2012). Patients with schizophrenia fail to up-regulate task-positive and down-regulate task-negative brain networks: An fMRI study using an ICA analysis approach. Frontiers in Human Neuroscience.
- (2012). An fMRI study of neuronal activation in schizophrenia patients with and without previous cannabis use. Frontiers in Human Neuroscience.
- (2012). Admissions to a Norwegian emergency psychiatric ward: patient characteristics and referring agents. A prospective study. Nordic Journal of Psychiatry. 40-48.
- (2011). Sexual dysfunction and hyperprolactinemia in male psychotic in-patients: a cross-sectional study. Advances in Urology. 686924.
- (2011). Neurocognitive effectiveness of quetiapine, olanzapine, risperidone, and ziprasidone: a pragmatic, randomized trial. European psychiatry.
- (2011). Cardiovascular risk in patients admitted for psychosis compared with findings from a population-based study. Nordic Journal of Psychiatry. 192-202.
- (2011). Anti-depressive effectiveness of olanzapine, quetiapine, risperidone and ziprasidone: a pragmatic, randomized trial. BMC Psychiatry. 10 pages.
- (2010). Suicide risk and acute psychiatric readmissions: A prospective cohort study. Psychiatric Services. 25-31.
- (2010). Effectiveness of second-generation antipsychotics: a naturalistic, randomized comparison of olanzapine, quetiapine, risperidone, and ziprasidone. BMC Psychiatry. 13 pages.
- (2010). A 1H-MR spectroscopy study of changes in glutamate and glutamine (Glx) concentrations in frontal spectra after administration of memantine. Cerebral Cortex. 798-803.
- (2009). Treatment of schizophrenia with antipsychotics in Norwegian emergency wards, a cross-sectional national study. BMC Psychiatry. 9 pages.
- (2009). The effects of the glutamate antagonist memantine on brain activation to an auditory perception task. Human Brain Mapping. 3616-3624.
- (2009). Evidence for glutamatergic neurotransmission in cognitive control in an auditory attention task. Neuroscience Letters. 171-175.
- (2009). Acute clozapine exposure in vivo induces lipid accumulation and marked sequential changes in the expression of SREBP, PPAR, and LXR target genes in rat liver. Psychopharmacology. 73-84.
- (2008). Left hemisphere lateralisation of auditory hallucinations in schizophrenia: A dichotic listening study. Cognitive Neuropsychiatry. 166-179.
- (2008). Auditory hallucinations in schizophrenia: the role of cognitive, brain structural and genetic disturbances in the left temporal lobe. Frontiers in Human Neuroscience. 10 pages.
- (2008). Antipsychotic-induced hyperprolactinemia: A cross-sectional survey. Journal of Clinical Psychopharmacology. 686-690.
- (2007). Gene expression profiles in rat brain disclose CNS signature genes and regional patterns of functional specialisation. BMC Genomics.
- (2006). Positive symptoms and duration of illness predict functional laterality and attention modulation in schizophrenia. Acta Psychiatrica Scandinavica. 322-331.
- (2006). Glycerophospholipid molecular species in platelets and brain tissues - are platelets a good model for neurons? Platelets. 484-492.
- (2006). Antipsykotikaindusert hyperprolaktinemi. Tidsskrift for Den norske legeforening. 179-180.
- (2004). Practice regarding antipsychotic therapy: A cross-sectional survey in two Norwegian hospitals. Nordic Journal of Psychiatry. 313-317.
- (2004). Dichotic listening in schizophrenic patients: effects of previous vs. ongoing auditory hallucinations. Psychiatry Research. 167-174.
- (2003). Oral dyskinesias and histopathological alterations in substantia nigra after long-term haloperidol treatment of old rats. Neuroscience. 717-725.
- (2003). Memantine attenuates the increase in striatal preproenkephalin mRNA expression and development of haloperidol-induced persistent oral dyskinesias in rats. Brain Research. 188-192.
- (2002). Medikamentell behandling av schizofreni. Tidsskrift for Den norske legeforening. 2206-2209.
- (2002). Functional brain asymmetry and attention modulation in young and stabilised schizophrenic patients: A dichotic listening study. Psychiatry Research. 281-287.
- (2001). Oral dyskinesias and morphological changes in striatum in rats during long-term haloperidol treatment. Psychopharmacology. 11-19.
- (2000). Reduced number of striatal neurons expressing preprosomatostatin mRNA in rats with oral dyskinesias after long-term haloperidol administration. Neuroscience Letters. 21-24.
- (2000). No changes in dopamine D(1) receptor mRNA expressing neurons in the dorsal striatum of rats with oral movements indured by long-term haloperidol administration. Brain Research. 394-397.
- (2000). Neurotoxicity associated with neuroleptic-induced oral dyskinesias in rats. Implications for tardive dyskinesia? Progress in Neurobiology. 525-541.
- (2000). Decreased number of neurons expressing preprosomatostatin mRNA in stratium of haloperidol treated rats. Journal of Neuroscience.
- (2000). Decreased number of neurons expressing preprosomatostatin mRNA in stratium of haloperidol treated rats. Journal of Neuroscience.
- (1999). The relationship between oral dyskinesias produced by long-term haloperidol treatment, the density of striatal preproenkephalin messenger RNA and enkephalin peptide, and the number of striatal neurons expressing preproenkephalin messenger RNA in rats. Neuroscience. 27-35.
- (1999). Hemispheric asymmetry in schizophrenia: A «dual deficits» model. Biological Psychiatry.
- (1999). Coenzyme Q10 does not prevent oral dyskinesias induced by long-term haloperidol treatment of rats. Pharmacology, Biochemistry and Behavior. 637-642.
- (1996). Inhibition by memantine of the development of persistent oral dyskinesias induced by long-term haloperidol treatment of rats. British Journal of Pharmacology. 751-757.
- (1996). Inhibition by memantine of the development of persistent oral dyskinesias induced by long-term haloperidol treatment of rats. British Journal of Pharmacology. 751-757.
- (1996). Correlation of vacuous chewing movements with morphological changes in rats following 1-year treatment with haloperidol. Psychopharmacology. 238-247.
- (1996). Correlation of vacuous chewing movements with morphological changes in rats following 1-year treatment with haloperidol. Psychopharmacology. 238-247.
- (1994). The relationship between motor effects in rats following acute and chronic haloperidol treatment. Psychopharmacology. 89-92.
- (1994). The mitochondrial toxin 3-nitropropionic acid induced oral movements in rats. Neuroscience abstracts. 1188.
- (1994). The mitochondrial toxin 3-nitropropionic acid induced oral movements in rats. Neuroscience abstracts. 1188.
- (1994). The kindling hypothesis for tardive dyskinesia: The effect of long-term daily intracerebroventricular haloperidol injections in rats. Pharmacology, Biochemistry and Behavior. 309-312.
- (1994). The effect of ganglioside GM1 on haloperidol-induced behaviour in rats. Psychopharmacology. B4.
- (1994). GM1 ganglioside attenuates the development of vacuous chewing movements induced by long-term halperidol treatment of rats. Psychopharmacology. 517-522.
- (1994). Decreased number of somatostatin mRNA containinag neurons in striatum of haloperidol treated rats. Neuroscience abstracts. part 2, 989.
- (1993). The kindling hypothesis for tardive dyskinesia: The effect of long-term daily intracerebroventricular haloperidol injections in rats. Pharmacology, Biochemistry and Behavior.
- (1993). The ganglioside GM1 attnuates the development of haloperidol-induced oral movements in rats. Neuroscience abstracts. 1776.
- (1993). Relationship between motor effects in rats following acute and longterm neuroleptic treatment. Neuroscience abstracts. 598.
Report
- (1998). Evaluering av undervisningen i psykiatri ved Universitetet i Bergen. .
Popular scientific lecture
- (2005). Hvordan forskningen kan styrke psykiaterens fag- og kompetanseutvikling.
- (2002). Schizofreni:Hva vet vi om biologiske årsaksforhold og hvordan skal lidelsen behandles.
Academic lecture
- (2015). Predictors of severe self-harm in patients discharged from psychiatric hospital. A prospective cohort study.
- (2005). Suicidality in psychiatric emergency admissions – the SIPEA study.
- (2005). Medikamentell behandling i akuttpsykiatrien.
- (2005). Hyperdopaminerge syndromer: Dopamins rolle ved psykoser.
- (2005). Hva finnes av ny forskning omkring schizofreni?
- (2005). Antipsykotisk behandling.
- (2004). Positive symptoms, duration of illness and medication predict dichotic listening performance in 129 scizophrenic patients.
- (2004). Left temporal lobe contribution to hallucinations in schizophrenia: A dichotic listening study.
- (2004). Antipsychotic-induced changes in global gene expression: Demonstration of novel mechanisms of drug action based on clustering and verification of differential expressed genes.
- (2003). Å få det til å blomstre..... Hvilke grep må vi ta for å komme på "Norgestoppen".
- (2003). Tardive dyskinesier: Nevroleptikas innvirkning på basalgangliene.
- (2003). Status innen farmakologi/biologi.
- (2003). Diagnostikk og klinikk: Affektive syndromer og psykose - avgrensning og overgangstilstander.
- (2003). Biologiske terapiformer: antidepressiva, stemningsstabiliserende stoffer.
- (2003). Biologisk perspektiv på schizofreni og schizofrenibehandling.
- (2002). Use of Antipsychotics and Mood Stabilizers during pregnancy.
- (2002). Schizofreniens anatomi.
- (2002). Nevroleptika. Pharmakokinetikk og dynamikk. Kliniske problemstillinger og val av preparat.
- (2002). Medikamenter ved psykoser hos barn og unge.
- (1996). Striatal lesions and oral dyskinesias in rats after co-treatment with haloperidol and 3-nitropropionic acid.
- (1996). Striatal lesions and oral dyskinesias in rats after co-treatment with haloperidol and 3-nitropropionic acid.
- (1996). Haloperidol-induced persistent oral movements in rats inhibited by memantine.
- (1993). The kindling hypothesis for tardive dyskinesia: the effects of repeated daily intracerebroventricular haloperidol injections in rats.
- (1993). The ganglioside GM1 attenuates the development of haloperidol-induced oral movements in rats.
- (1993). Tardive dyskinesia: a striatal injury?
- (1993). Relationship between motor effects in rats following acute and long-term neuroleptic treatment.
Editorial
- (2006). The treatment environment. Nordic Journal of Psychiatry. 77.
Book review
- (2002). Fortsatt førstevalget i psykofarmakologi. (Lingjærde, O.:"Psykofarmaka: Medikamentell behandling av psykiske lidelser." 4. utg.). Tidsskrift for Den norske legeforening. 539.
Non-fiction book
- (1991). Rehabilitering av pasienter med kronisk alvorlig sinnslidelse. [Mangler utgivernavn].
Popular scientific article
- (2002). Uro fremkalt av medikamenter. Bergens Tidende.
- (1998). Bredere effekt og færre bivirkninger. Legemidler og samfunn. 48-50.
- (1998). Bedre effekt og færre bivirkninger. Legemidler og samfunn. 48-50.
Feature article
- (1998). Antipsykotika og bivirkninger. Tidsskrift for Den norske legeforening. 4337-4338.
Doctoral dissertation
- (2017). Predictors of suicidality and self-harm related admissions to psychiatric and general hospitals.
- (2017). Predictors of self-harm related admissions to psychiatric and general hospitals.
- (1996). Tardive dyskinesia. An exitotoxicity hypothesis investigated in a rat model. -.
Interview
- (2006). Vanskelig å konkludere.
- (2005). Mange brikker i et sammensatt bilde.
- (2005). CATIE-studien vedrørende virkning og bivirkninger av antipsykotika.
- (2004). Vrangforestillinger og press kan utløse vold.
- (2004). Vrangforestillinger og press kan utløse vold.
- (2004). Søker i genane for betre behandling av psykoser.
- (2004). Systemet hindrer god behandling.
- (2003). Schizophreni dyrere for samfunnet enn fysisk skykdom.
- (2002). Tradisjonelle antipsykotika utgått på dato.
- (2002). Nyere antipsykotikum mangedobler diabetesrisikoen.
Programme participation
- (2004). Undersøkelse av pasient med MRI og demonstrasjon av hva en slik undersøkelse kan bidra med innen psykiatrien.
Academic chapter/article/Conference paper
- (2008). An introduction to schizophrenia. 15 pages.
- (2004). Behandling.
- (2002). Kjell Hole and psychiatry in Bergen. 4 pages.
- (1993). Blåbærlia-Avdelingen for unge schizofrene ved Sandviken sykehus. 4 pages.
Encyclopedia article
- (2001). Psykoser. 181-185. In:
- (2001). Norsk legemiddelhåndbok for helsepersonell 2001.
- (2001). Antipsykotika. 806-815. In:
- (2001). Norsk legemiddelhåndbok 2001.
Abstract
- (2014). C-reactive protein levels are inversely associated with neurocognitive performance in acutely admitted patients with psychosis. Schizophrenia Research. 131.
- (2013). Cognitive changes in non-affective psychosis the first 4-6 weeks after admission to a psychiatric acute ward: effects of substance use. Schizophrenia Research.
- (2012). Neurocognitive functions recover from acute phase to three month-follow up in patients with non-affective psychotic disorders. Journal of the International Neuropsychological Society.
- (2012). Clinical differences in acute-phase non-affective psychotic disorders with and without substance use. Schizophrenia Research.
- (2011). CANNABIS USE AND BRAIN FUNCTIONING IN SCHIZOPHRENIA: AN FMRI STUDY. Schizophrenia Bulletin. 144-145.
- (2010). Prediction of un-planned readmission to hospital for patients with schizophrenia - a cohort-study of 277 patients. European Neuropsychopharmacology. S444-S445.
- (2010). Left temporal dysfunction, attention control deficit and auditory hallucinations: An fMRI study. Schizophrenia Research. 352.
- (2010). ANTI-DEPRESSIVE EFFECTIVENESS OF OLANZAPINE, QUETIAPINE, RISPERIDONE, AND ZIPRASIDONE: A RANDOMIZED, NATURALISTIC STUDY. Schizophrenia Research. 377-378.
- (2007). Antipsychotic-induced hyperprolactinemia and associated symptoms: A cross-sectional survey. Nordic Journal of Psychiatry. 498-498.
- (2006). Suicidality in psychiatric emergency admissions: the SIPEA study, a prospective follow-up study. Psychiatria Danubina. 140-140.
- (2006). Left hemisphere contribution to hallucinations in schizophrenia: A dichotic listening study. Schizophrenia Research. 27-27.
- (2005). Depression and acupuncture:research with fMRI. Psychiatriki. 252.
- (2004). Positive symptoms, duration of illness and medication predict dichotic listening performance in 129 schizophrenic patients. Schizophrenia Research. 85-85.
Poster
- (2018). Longitudinal relationship to cognitive function in acute phase of psychosis in a pragmatic, randomized trial.
- (2017). The C-reactive protein in schizophrenia-spectrum disorders: relationship to cognitive function in acute phase of psychosis with a longitudinal perspective in a pragmatic, randomized trial .
- (2009). Differential effects of four second-generation antipsychotics on cognition in acute psychosis.
- (2008). The effects of glutamate antagonist memantine on brain activation in an auditory discrimination task. A pharmacological fMRI study.
- (2007). Attention modulation may be regulated through glutamate: Implications for mental disorders? An pharmacological fMRI study.
- (2007). Attention modulation may be regulated through glutamate: A pharmacological fMRI study.
- (2005). Schizophrenia and Acupuncture.
- (2005). Depression and Acupuncture: Research with fMRI.
- (2005). Depression and Acupuncture.
- (2004). Positive symptoms, duration of illness and medication predict dichotic listening performance in 129 schizophrenic patients.
- (2003). Oral dyskinesias and histopathology in substantia nigra after long-term haloperidol treatment of old rats.
- (2003). Antipsychotic-induced changes in global gene expression: Demonstration of novel mechanisms of drug action based on clustering and verification of differential expressed genes.
- (2002). Memantine attenuated the increase in striatale enkephalin expression associated with haloperidol-induced persistent oral dyskinesias in rats.
- (2001). Neurocognition of schizophrenia.
- (2001). Functional brain asymmetri and auditory hallucinations in schizophrenia.
- (2000). Visual search in schizophrenia.
- (2000). Creatine does not prevent haloperidol-induced oral dyskinesias in rats.
Academic literature review
- (2008). Effectiveness of second generation antipsychotics: A systematic review of randomized trials. BMC Psychiatry. 14 pages.
More information in national current research information system (CRIStin)